Is clinical disease activity index (CDAI) a reliable parameter in the assessment of rheumatoid arthritis patients treated with TNF antagonists?

被引：0
|
作者：
Inanc, N. [1 ]
Direskeneli, H. [1 ]
机构：
[1] Marmara Med Sch, Div Rheumatol, Istanbul, Turkey
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：173 / 173
页数：1
相关论文
共 50 条
  • [1] The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): A review of their usefulness and validity in rheumatoid arthritis
    Aletaha, D
    Smolen, J
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (05) : S100 - S108
  • [2] Validation of Clinical Disease Activity Index (CDAI) and Simplified Disease Activity Index (SDAI) in Rheumatoid Arthritis (RA) in Algeria
    Slimani, S.
    Abbas, A.
    Rahal, F.
    Ali, E. H.
    Dahou-Makhloufi, C.
    Ladjouze-Rezig, A.
    CLINICAL RHEUMATOLOGY, 2013, 32 : S127 - S127
  • [3] Improved clinical and simplified disease activity index (CDAI, SDAI) scores with rituximab in patients with rheumatoid arthritis (RA) and an inadequate response to TNF inhibitors
    Smolen, Josef
    Cividino, Alfred
    Kavanugh, Arthur
    Tony, Hans Peter
    Greenwald, Maria
    De Vita, Salvatore
    Brasington, Richard
    Aletaha, Daniel
    White, Anne Marie
    Hessey, Eva
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1191 - 1191
  • [4] ASSESSMENT OF DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS BY ROUTINE ASSESSMENT OF RHEUMATOID ARTHRITIS DISEASE ACTIVITY INDEX (RADAI) AND ITS RELATION WITH DISEASE ACTIVITY SCORE 28 (DAS28), CLINICAL DISEASE ACTIVITY INDEX (CDAI) AND SIMPLIFIED DISEASE ACTI
    Kaygisiz, F.
    Borman, P.
    Tuncay, F.
    Okumus, M.
    Erdem, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 838 - 838
  • [5] ASSESSMENT OF THE CLINICAL DISEASE ACTIVITY INDEX (CDAI) INRHEUMATOID ARTHRITIS PATIENTS BY NURSES IS HIGHLY CORRELATED WITH RHEUMATOLOGIST'S
    White, K.
    Aslanov, R.
    Khraishi, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1192 - 1192
  • [6] Clinical Disease Activity Index (CDAI) is a valid instrument for assessing disease activity amongst oriental early rheumatoid arthritis (ERA) patients.
    Lian, Tsui Y.
    Koh, Ee T.
    Kong, Kok O.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S377 - S378
  • [7] Association of ACR Clinical Responses with CDAI (Clinical Disease Activity Index) and RAPID3 (Routine Assessment of Patient Index Data 3) Indices of Disease Activity in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol Plus Methotrexate
    Schiff, Michael H.
    Luijtens, Kristel
    Davies, Owen
    Yazici, Yusuf
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S490 - S490
  • [8] Rituximab significantly improves the clinical and simplified disease activity index (CDAI, SDAI) scores in patients with rheumatoid arthritis (RA) and an inadequate response to TNF inhibitors (REFLEX)
    Smolen, J.
    Kavanaugh, A.
    Tony, H. P.
    Greenwald, M.
    De Vita, S.
    Brasington, R.
    Aletaha, D.
    White, A. M.
    Hessey, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 439 - 439
  • [9] T cell responses in rheumatoid arthritis patients treated with TNF antagonists
    Roumanes, David
    Kobie, James
    Cavenaugh, James
    Quataert, Sally
    Mosmann, Tim
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [10] MALIGNANCIES IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TNF-ALPHA ANTAGONISTS
    Ozguler, Y.
    Esatoglu, S. N.
    Keskin, D.
    Hatemi, G.
    Hamuryudan, V.
    Pala, A. S.
    Ugurlu, S.
    Tascilar, K.
    Melikoglu, M.
    Seyahi, E.
    Fresko, I.
    Ozdogan, H.
    Yurdaku, S.
    Ongen, G.
    Yazici, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1040 - 1040
12345